Malaria causal prophylactic activity of imidazolidinedione derivatives

Journal of Medicinal Chemistry

Volumn 50, Issue 24, 2007, Pages 6226-6231

  Guan, Jian ^a   Wang, Xihong ^a   Smith, Kirsten ^b   Ager, Arba ^c   Gettayacamin, Montip ^d   Kyle, Dennis E ^d   Milhous, Wilbur K ^a   Kozar, Michael P ^a   Magill, Alan J ^a   Lin, Ai J ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDE; CHLOROQUINE; GUANIDINE DERIVATIVE; IMIDAZOLINE DERIVATIVE; PRIMAQUINE; TRIAZINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROTOZOAL ACTIVITY; ARTICLE; CONTROLLED STUDY; MALARIA; NONHUMAN; PARASITEMIA; PLASMODIUM CYNOMOLGI; PLASMODIUM YOELII; RELAPSE; RHESUS MONKEY; SPOROZOITE; TREATMENT OUTCOME;

ANIMALS; ANTIMALARIALS; GUANIDINES; HUMANS; IMIDAZOLIDINES; MALARIA; MICE; MICROSOMES, LIVER; PLASMODIUM CYNOMOLGI; PLASMODIUM YOELII; RATS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 37849003826     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm7009815     Document Type: Article

References (22)

1. Trigg, P. I.; Kondrachine, A. V. The current global malaria situation. In Malaria Parasite Biology, Pathogenesis and Protection; Sherman, I. W., Ed.: ASM Press: Washington, D.C., 1998; Chapter 2, pp 11-22,
2. World Health Organization. World malaria situation in 1994. Wkly. Epidemiol. Rec. 1997, 72, 269-76.
3. Greenberg, A. E.; Lobel, H. O. Mortality from Plasmodium falciparum; malaria in travelers from the United States, 1959-1987. Ann. Intern. Med. 1990, 113, 326-27.
4. White, N. J. Drug resistance in malaria. Br. Med. Bull. 1998, 54, 703-715.
5. Nosten, F.; Ter Kuile, F.; Chongsuphajaisiddhi, T.; Luxemburger, C.; Webster, H. K.; Edstein, M.; Phaipun, L.; White, N. J. Mefloquine-resistant falciparum malaria on the Thai-Burmes border. Lancet 1982, 337, 1140-1143.
6. Oduola, A. M.; Milhous, W. K.; Salako, L. A.; Walker, O.; Desjardins, R. E. Reduced in vitro susceptibility to mefloquine in West African isolates of Plasmodium falciparum. Lancet 1987, 2, 1304-1305.
7. Carson, P. E.; Flanagan, C. I.; Ickes, C. E.; Alvin, A. S. Enzymatic deficiency in primaquine-sensitive erythrocytes. Science 1956, 124, 484-485.
8. Carson, P. E.; Hohl, R.; Nora, M. V.; Parkhurst, G. W.; Ahmad, T.; Scanlan, S.; Frischer, H. Toxicology of the 8-aminoquinolines and generic factors associated with their toxicity in man. Bull. W. H. O. 1981, 59, 427-437.
9. Schmidt, L. H.; Frank, R.; Genther, C. S.; Rossan, R. N.; Squires, W. I. The characteristics of untreated sporozoite-induced and trophozoite-induced infections. Am. J. Trop. Med. Hyg. 1982, 31, 612-645.
10. Schmidt, L. H.; Frank, R.; Genther, C. S.; Rossan, R. N.; Squires, II, W. Responses of Sporozoite-induced and trophozoite-induced infections to standard antimalarials drugs. Am. J. Trop. Med. Hyg. 1982, 31, 646-665.
11. Puri, S. K.; Dutta, G. P. Quinoline esters as potential antimalarial drugs: effect on relapses of Plasmodium cynomolgi infections in monkeys. Trans. R. Soc. Trop. Med. Hyg. 1990, 84, 759-60.
12. Peters, W. The evolution of tafenoquine-antimalarial for a new millennium? J. R. Soc. Med. 1999, 92, 345-52.
13. Walsh, D. S.; Wilairatana, P.; Tang, D. B.; Heppner, D. G., Jr.; Brewer, T. G.; Krudsood, S.; Silachamroon, U.; Phumratanaprapin, W.; Siriyanonda, D.; Looareesuwan, S. Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse. Clin. Infect. Dis. 2004, 39, 1095-103.
14. Walsh, D. S.; Eamsila, C.; Sasiprapha, T.; Sangkharomya, S.; Khaewsathien, P.; Supakalin, P.; Tang, D. B.; Jarasrumgsichol, P.; Cherdchu, C.; Edstein, M. D.; Rieckmann, K. H.; Brewer, T. G. Efficacy of Monthly Tafenoquine for Prophylaxis of Plasmodium vivax and Multidrug-resistant P. falciparum Malaria. J. Infect. Dis. 2004, 190, 1456-63.
15. Corcoran, K. D.; Hansukjariya, P.; Sattabongkot, J.; Ngampochjana, M.; Edstein, M. D.; Smith, C. D.; Shanks, G. D.; and Milhous. W. K. Causal prophylactic and radical curative activity of WR182393 (a guanylhydrazone) against Plasmodium cynomolgi in Macaca mulatta. Am. J. Trop. Med. Hyg. 1993, 49, 473-477.
16. Guan, J.; Zhang, Q.; Gettayacamin, M.; Karle, J. M.; Ditusa, C. A.; Milhous, W. K.; Skillman, D. R.; Lin, A. J. Structure identification and prophylactic antimalarial efficacy of 2-guanidinoimidazolidinedione derivatives. Bioorg. Med. Chem., 2005, 13, 699-704.
17. Zhang, Q.; Guan, J.; Sacci, J.; Ager, A.; Ellis, W. Y.; Milhous, W. K.; Kyle, D. E.; Lin, A. J. Unambiguous synthesis and prophylactic antimalarial activities of imidazolidinedione derivatives. J. Med. Chem., 2005, 48, 6472-6481.
18. Lin, A. J.; Zhang, Q.; Guan, J.; Milhous, W. K. 2- Guanidinylimidazolidinedione Compounds of Making and Using Thereof. U.S. Patent Number 7,101,902, September 5, 2006.
19. Schmidt, L. H.; Alexander, S.; Allen, L.; Jane Rasco, J. Comparison of the curative antimalarial activities and toxicities of primaquine and its D and L Isomers. Antimicrob. Agents Chemother. 1977, 12, 51-60.
20. Smith, C. C.; Ihrig, J.; Menne, R. Antimalarial activity and metabolism of biguanides. Am. J. Trop. Med. Hyg. 1961, 10, 694-703.
21. Watkins, W. M.; Sixsmith, D. G.; Chulay, J. D. The activity of proguanil and its metabolites, cycloguanil and p-chlorophenylbiguanide, against Plasmodium falciparum in vitro. Ann. Trop. Med. Parasitol. 1984, 78, 273-278.
22. Kinyanjui, S. M.; Mberu, E. K.; Winstanley, P. A.; Jacobus, D. P.; Watkins, W. M. The antimalarials triazine WR99210 and the prodrug PS-15: folate reversal of in vitro activity against Plasmodium falciparum and a non-antifolate mode of action of the prodrug. Am. J. Trop. Med. Hyg. 1999, 60, 943-947.